March 12, 2007
Abrevity
Joel Harrison
CTO
How has your company adapted and responded to the changing economic climate in the past five years when so many others companies did not?
Abrevity was founded in 2003 and self funded until 2005. We knew when we built the company that initially getting outside funding would be difficult because of the economic climate at that time but knew that our core technology and value proposition could not wait until the climate changed. In 2005 we took our first product to market and it was successful which allowed us to quickly grow the company.
What is your vision for the future of the life sciences market over the next several years?
One of the biggest IT pains in the life sciences market today is managing the issue of exponential data growth. Abrevity will continue to advance our products in the data management aspect of life sciences. We see our products becoming the leading product in managing large amounts of clinical research, pharma, and life science experiment data.
What products and services does your company provide and what special capabilities do they offer the life sciences market?
Abrevity’s FileData Classifier and FileData Manager products with the addition of our Bio Extraction module allows data being created by bio-instruments such as Flow Cytometers and Microscopes to the indexed, search, classified (tagged), and managed. Our unique technology allows users to manage the files associated with experiments as a single object or “classification bucket”. This allows pertinent data to be mined out of the files while keeping a full index of the other data for future use.
Partnerships are an effective way to track life science advances and ensure that your company delivers timely products and services. Which life sciences companies or organizations have you partnered with or invested in and why?
We have worked closely with instrument manufacturers and research firms such as BD Biosciences because we have expertise in data management and they have the expertise in the life sciences instruments.
What are your most exciting products and initiatives in development, and how will they improve life science research?
We are excited about the fact that our products allow Scientists, Researchers, and Bio-IT professionals to spend more time doing their core job, and not spending time manually managing data. We think that we can help speed up research by removing the daunting tasks of administration, data mining, report generation, and audit compliance.
Where do you see your company in five years?
In five years, we will be the leading application and data management framework vendor to manage all types of unstructured, semi-structured, and structured data.